CardioBrief

One-stop source for cardiology news and links

Main menu

Skip to content
  • Home
  • About
  • CardioBrief Rebel Mouse
    • The Controversy Over The TACT Chelation Trial

Tag Archives: awards

March 29, 2012

And the 2012 Award For the Most Dumbass Drug Promotion Goes To… 7

by Larry Husten • People, Places & Events, Policy & Ethics • Tags: awards, rivaroxaban, Xarelto

The year 2012 is only 25% complete but it’s never too early to recognize an unprecedented and bold achievement in drug marketing. More…

About these ads

Post navigation

Note to Readers: A Time For Change

Click here to read about important new changes to CardioBrief.

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 6,464 other followers

Follow CardioBrief via Twitter

Follow @cardiobrief

Follow CardioBrief VIA RSS

RSS Feed RSS - Posts

CardioBrief Tweets

  • @adamfeuerstein even non Trekkies like me know it's K... 13 hours ago
  • I had a random lunch encounter with Mommy bloggers: thelilmamas.com yfrog.com/g0rb4yfj 1 day ago
  • RT @adamfeuerstein: $AMRN - No Vascepa NCE decision... again. 1 day ago
  • Thoratec wins FDA nod for HeartMate controller - FierceMedicalDevices: fiercemedicaldevices.com/story/thoratec… 1 day ago
  • @adamhewitt198 @fivethirtyeight @bengoldacre Politicians lie to others. Pharma Execs/MDs lie to themselves. 1 day ago
  • @Richard56 And what about the lack of expression on the faces of the Pieros? 1 day ago
  • 1. Crestor 2. Diovan 3. Lipitor 4. Zetia 5. Benicar 6. Micardis 7. Avapro 8. Vytorin 9. Blopress 10. Tracleer 2 days ago
  • FiercePharma Top 10 Cardio Drugs 2012: fiercepharma.com/special-report… 2 days ago
  • Kenneth Mahaffey quits DCRI for Stanford | theheart.org theheart.org/article/154081… 2 days ago
  • Congrats to Harlan Krumholz, well-deserved AHA QCOR award winner. ow.ly/l6dWt >I'm proud to work with him on CardioExchange 2 days ago
  • Smith: When I was “doing the hippy trail” in 1973 my friend passed out when an Indian doctor took my blood pressure. 2 days ago
  • Richard Smith's BMJ blog: Reclaiming blood pressure from doctors blogs.bmj.com/bmj/2013/05/16… 2 days ago
  • Half of researchers have reported trouble reproducing published findings: MD Anderson survey wp.me/pYKlt-3Gs via @wordpressdotcom 2 days ago
  • Astonishing that there were no criminal prosecutions in the Ranbaxy case. If ever it was justified… 3 days ago
  • "Every single [FDA] inspector that went to India said they would never take a Ranbaxy drug" 3 days ago
  • Remarkably, Ranbaxy is in a stronger position now in the U.S. than it was before its entanglement with the FDA. 3 days ago
  • ...supervisors who had supposedly overseen critical manufacturing steps weren't even at the plant on the days they signed off on the tests. 3 days ago
  • if the drugs were an ongoing threat, why hadn't the FDA stopped Ranbaxy from selling them? 3 days ago
Follow @cardiobrief

CardioBrief Classics

Coca-Cola, The Olympic Torch, And The American College Of Cardiology
Stem Cell Therapy Company Hypes Preliminary Results
Good Science/Bad Science: Contrasting Papers On Dietary Compositon In JAMA And BMJ
Subway Meals Get American Heart Association Endorsement
This Week In Medicine: Stop Exercising and Eat Chocolate!
You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook
Politics and Transcatheter Aortic Valve Replacement
Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes
New Perspective on the Dutch Cardiovascular Research Scandal
Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart
And the 2012 Award For the Most Dumbass Drug Promotion Goes To…
You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook
Politics and Transcatheter Aortic Valve Replacement
Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes
Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart
Guest Post: More Lessons From the Riata ICD Lead Recall
Japanese Researcher With Harvard Connections Retracts 3 Articles in AHA Journals
Lancet Editor Richard Horton Tweets Dark View of Contemporary Medicine
Resveratrol and Fraud
Director of UConn CV Research Center Accused of Scientific Misconduct
2011 in Review: Rivaroxaban, Sapien, Mark Midei, Conflicts of Interest, and Much More
Nissen and Topol Clash Over Genetics and Personalized Medicine
Ray of Light for the Physician Payment Sunshine Act
Letter From Jail: A Cautionary Tale
One More Thought About Lipitor
Experts Clash Over Interpretation and Value of AIM-HIGH
Controversy Over Cholesterol Testing for Children
CardioBrief Poll: Should the ACC Train Industry Reps?
Daily Show Asks Why the AHA Killed a Bill Encouraging Healthy Behavior
National Lipid Association Expert Panel Has Many Deep Ties To Industry
Industry & Medicine: It’s Complicated
Easy Come, Easy Go? ESC To Review Dronedarone’s Role in AF Guidelines
The Pen Is Mightier Than the Scold
CNN Documentary Promises Screening and Vegan Diet Can Eliminate Heart Attacks
CNN, ABC, and NBC Dumb Down the News About CV Screening
US Senate Unanimously Endorses Campaign Against Atrial Fibrillation
Less May Be More, But Stents Are Neither Good Nor Bad
The Voice of the Patient: Time To Bring Out the Muzzle?
New Concerns Raised About Withdrawn Archives Meditation Paper
Archives Decides At Last Minute Not to Publish a Scheduled Paper
Part 2: The National Lipid Association And Industry
Part 1: The National Lipid Association and the FH Guidelines
Understanding Risk: Tricky Business
ACC CEO Jack Lewin Provides The Argument Against Industry Money
The ACC Counts Down To Launch Of New Satellites
Scientific Fraud Found In Wayne Alexander’s Research Group At Emory
$50K: The Price For A VIP Dinner For 2 With The Cleveland Clinic CEO
Evidence: The Weak Link Of Evidence-Based Medicine
Taking Medical Advice From Peggy Fleming?
The ACC Wants You To Know That Nothing Is Rotten In The State Of Maryland
An Embargo Becomes A Public Relations Tool
PROTECT II: Who Will Protect Us From The Protectors?
GRAVITAS Published: Who Gets To Weigh In On the Results?
WebMD: the 800 Pound Gorilla in the Room
Some Things Don’t Go Better With Coke
ACC and HRS Downplay Data From Their Own Registry
Dangling Doctors In Front of Journalists
Spinning Out of Control: Another Look at the PROTECT II Press Release
Questions Raised About Compensation and Conflicts at Duke
SHARP: A Tale of Two Press Releases
Will This Be the HDL Decade? REVEAL Revealed, Mixed Results for Apo-A1
CardioExchange at the AHA: A New Voice Emerges
Top New York City Interventional Cardiologists Now Making $3 Million a Year
The Plot Thickens in the Case of the Exploding ICD
Red light or green light for AAA screening?
Blue light special: AAA screening at Kmart in the disease-mongering aisle
The rise of the ESC: is the ESC anti-American or pro-industry?
Dronedarone and ticagrelor speed into ESC guidelines
The debate over CME and industry influence continues
Avandia aftermath: who are the winners and losers?
Debating medical promotion and education
Why is there a red dress on diet Coke cans?
SHAPE shifting: transforming guidelines into a business venture
Why was an Abbott marketing study published in the American Journal of Cardiology?
At the Dallas valve meeting even the faculty is for sale
A missing piece of the Multaq puzzle finally appears: DIONYSOS published to little fanfare
EHJ editors rebuffed GSK efforts to suppress Nissen editorial on rosiglitazone
“Is it safe?”
Why we shouldn’t kill all the lawyers just yet
Why is there a red dress on diet Coke cans?
Sunday at the AHA: ARBITER’s wild roller coaster ride in Orlando
Cardiology $$$: Mt Sinai’s Samin Sharma tops Columbia’s Moses
Residual Risk Reduction Initiative: promotion or education?
Editorial: the incompetence of the FDA
Editorial: SHAPE is skating on thin ice
Extreme cardiology culture: Califf, Harrington, Topol & Teirstein
October thought experiment: suppose the World Series were covered like the Nobel Prize
Live AF ablation broadcast on Today Show: what’s wrong with this picture?
More Multaq: Prystowsky whack-a-mole, ACC responds, Sanofi overtures to EPs
Pieces of a puzzle: Multaq, Sanofi, ACC, HRS, Prystowsky, AF Guidelines

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 6,464 other followers

Follow on Twitter

Follow @cardiobrief
My Google Plus Profile
Site Meter

  • Edward J. Schloss MD
  • Larry Husten

Top Posts

  • Instagram for Heart Attacks: iPhone App Speeds ECG Transmission To Hospital
  • Phentermine/Topiramate Combination Yields Significant Weight Loss
  • Salt Report From IOM Sparks Much Heat, Only A Little Light
  • Top New York City Interventional Cardiologists Now Making $3 Million a Year
  • BLOCK HF: A "Game Changer" For Cardiac Pacing
  • Bruise Control: Continued Warfarin Beats Heparin Bridging During Device Implantation
  • Another Disappointing Study For Fish Oil Supplements
  • The Plot Thickens in the Case of the Exploding ICD
  • Another Cleveland Clinic Study Links TMAO To Atherosclerosis
  • A Manhattan Project To End The Obesity Epidemic
  • AHA Releases New Recommendations For Management Of Acute VTE
  • Anticoagulation Update: New Agent For Urgent Anticoagulation Reversal, Pradaxa Label Revised

Archives

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009

Meta

  • Register
  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.com

Enter your email address to subscribe to CardioBrief and receive notifications of new posts by email.

Join 6,464 other followers

Follow on Twitter

Follow @cardiobrief

RSS Feed RSS - Posts

Archives

Recent Comments

Cardiology EP Doc on Heart Rhythm Society Advising…
eduardo on Resveratrol and Fraud
HEPARIN BASED T1 TRE… on Bruise Control: Continued Warf…
Larry Husten on Our Limitless Capacity For…
Alan Averson on Our Limitless Capacity For…

Meta

  • Register
  • Log in
  • Entries RSS
  • Comments RSS
  • Blog at WordPress.com.
Blog at WordPress.com. | Theme: Newsy by Automattic. Design by Themify.
Follow

Get every new post delivered to your Inbox.

Join 6,464 other followers

Powered by WordPress.com